✦ LIBER ✦

Autoantibodies to β-Amyloid and Neurotransmitters in Patients with Alzheimer's Disease and Senile Dementia of the Alzheimer Type

✍ Scribed by M.A. Myagkova; S.I. Gavrilova; N.N. Lermontova; Ya.B. Kalyn; N.D. Selezneva; G.A. Zharikov; I.V. Kolykhalov; T.V. Abramenko; T.P. Serkova; S.O. Bachurin

Book ID: 110362687
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 387 KB
Volume: 131
Category: Article
ISSN: 0007-4888
DOI: 10.1023/a:1017527508878

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatostatin-like immunoreactivity and n

Somatostatin-like immunoreactivity and neurotransmitter metabolites in the cerebrospinal fluid of patients with senile dementia of Alzheimer type and Parkinson's disease

✍ M. Strittmatter; D. Strubel; C. Reuner; F. Kuntzmann; H. Cramer 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 63 KB

Alzheimer changes in nondemented patient

Alzheimer changes in nondemented patients younger than sixty-five: Possible early stages of Alzheimer's disease and senile dementia of Alzheimer type

✍ Dr J. Ulrich 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

First episodes of behavioral symptoms in

First episodes of behavioral symptoms in Alzheimer's disease patients at age 90 and over, and early-onset Alzheimer's disease: Comparison with senile dementia of Alzheimer's type

✍ KOJI HORI; TATSURO ODA; TOSHIYASU ASAOKA; MASAHIRO YOSHIDA; SHOICHI WATANABE; RE 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Clinical trials with the cholinergic dru

Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)

✍ Albert Wettstein; René Spiegel 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e

Differential deposition of amyloid β pep

Differential deposition of amyloid β peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia

✍ Mattias Haglund; Raj Kalaria; Janet Y. Slade; Elisabet Englund 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 324 KB

EEG- and cognitive changes in Alzheimer'

EEG- and cognitive changes in Alzheimer's disease (AD) and senile dementia of AD-type (SDAT)

✍ M. Streifler; M. Simanyi; P. Fischer; W. Danielczyk 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 63 KB